Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

47.64
+4.309.92%
Post-market: 49.942.30+4.83%19:59 EST
Volume:36.86M
Turnover:1.72B
Market Cap:211.48B
PE:13.16
High:47.74
Open:46.37
Low:45.84
Close:43.34
52wk High:93.80
52wk Low:43.08
Shares:4.44B
Float Shares:3.19B
Volume Ratio:0.92
T/O Rate:1.16%
Dividend:1.69
Dividend Rate:3.54%
EPS(TTM):3.62
EPS(LYR):3.62
ROE:60.70%
ROA:17.43%
PB:7.40
PE(LYR):13.16

Loading ...

Goldman Sachs: Market Overpricing Novo Nordisk's Pricing Pressure, Oral Wegovy Key to Restoring Confidence

Deep News
·
Feb 06

Stock Track | Novo Nordisk Soars 5.08% on Share Buyback and TrumpRx Inclusion

Stock Track
·
Feb 06

24H | Hims Shares Plunge over 9% After FDA Chief Threatens Action on "Illegal Copycat Drugs". Novo, Eli Lilly Jump over 2% Each

Reuters
·
Feb 06

White House Debuts Drug-Buying Site TrumpRx, With Roughly 40 Medications -- WSJ

Dow Jones
·
Feb 06

Novo Nordisk Earnings Call: Growth Engine Meets 2026 Reset

TIPRANKS
·
Feb 06

February 6th's Top 20 U.S. Stocks by Trading Volume: Amazon Forecasts $200 Billion Capital Expenditure for the Year

Deep News
·
Feb 06

Novo Nordisk Warns of Legal Action Against Hims & Hers Over Compounded Weight-Loss Drug

Deep News
·
Feb 06

Stock Track | Novo Nordisk Plummets 8.17% Intraday as Hims & Hers Launches Cheaper Wegovy Copycat Pill

Stock Track
·
Feb 06

Novo Nordisk Publishes 2025 Annual Report

TIPRANKS
·
Feb 06

Novo Nordisk Launches DKK 3.8 Billion Share Buyback as Part of 2026 Repurchase Plan

TIPRANKS
·
Feb 06

Novo Nordisk Discloses Management Share Transfers Under Long-Term Incentive Plan

TIPRANKS
·
Feb 06

European Equities Decline as Novo Nordisk Slumps

Deep News
·
Feb 06

Hims & Hers Launches Compounded Version Of Wegovy, Novo Nordisk Threatens Legal Action

Benzinga_recent_news
·
Feb 06

Novo Nordisk Accuses Hims & Hers of 'Illegal Mass Compounding' Over Hims & Hers's Cheaper Wegovy Version -- 2nd Update

Dow Jones
·
Feb 06

Novo Nordisk warnt vor illegalen Semaglutid-Kopien von Hims & Hers

Reuters
·
Feb 05

Novo Nordisk issues statement on ‘inauthentic’ Hims & Hers semaglutide pill

TIPRANKS
·
Feb 05

Novo Nordisk CEO says buyers of $49 compounded Wegovy pill will be 'wasting' their money

Reuters
·
Feb 05

Novo Nordisk CEO Says People Taking Hims Compounded Pill Will Be 'Wasting $49' Because the Compound Will Not Be Absorbed - Call With Analysts

THOMSON REUTERS
·
Feb 05

Hims & Hers to Offer Copy of Novo's Wegovy Pill for $49 per Month, Reuters Reports

MT Newswires Live
·
Feb 05

Hims and Hers Health Stock Soars 12% and Novo-Nordisk Falls 6% After Hims and Hers Launches Copy of Wegovy Pill at $49

Reuters
·
Feb 05